GIOSTAR is a pioneer in innovative stem cell science and therapy, aiming to provide stem cell-based therapy to aid those suffering from degenerative or genetic diseases globally. With the support of leading scientists and clinicians, the company focuses on developing the most advanced stem cell-based technology. Their primary goal is to discover and develop unique stem cell-based therapies and products, offering promises for the treatment of previously incurable diseases through regenerative medicine. Established in 2000 and headquartered in the United States, GIOSTAR has been at the forefront of developing and utilizing stem cell-based clinical protocols for over twenty years. The company envisions continuing to lead in the field of stem cell science and providing affordable stem cell-based therapy for those in need.
There is no investment information
No recent news or press coverage available for GIOSTAR.